Vir Biotechnology, Inc. (VIR) — 10-Q Filings
All 10-Q filings from Vir Biotechnology, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Vir Bio Narrows Q3 Loss to $163M Amid Revenue Dip, R&D Cuts
— Nov 5, 2025 Risk: high
Vir Biotechnology, Inc. reported a significant net loss of $163.1 million for the three months ended September 30, 2025, an improvement from the $213.7 million -
Vir Bio's Revenue Plummets 90% Amid Collaboration Wind-Down
— Aug 6, 2025 Risk: high
Vir Biotechnology, Inc. reported a significant decrease in total revenue for the three and six months ended June 30, 2025, primarily due to reduced collaboratio -
Vir Biotechnology Files Q1 2025 10-Q Report
— May 8, 2025 Risk: low
Vir Biotechnology, Inc. filed its Q1 2025 10-Q report on May 8, 2025, for the period ending March 31, 2025. The company, based in San Francisco, CA, operates in -
Vir Biotechnology Files Q3 2024 10-Q
— Nov 4, 2024 Risk: medium
Vir Biotechnology, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its business -
Vir Biotechnology 10-Q: Q2 2024 Update
— Aug 1, 2024 Risk: medium
Vir Biotechnology, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported revenue from collaborations and contracts, with specific figure -
Vir Biotechnology, Inc. Files 10-Q for Period Ending March 31, 2024
— May 3, 2024 Risk:
Vir Biotechnology, Inc. (VIR) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. Vir Biotechnology reported financial results for the quarter ended Ma
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX